News
Lubrizol’s Apinovex™ polymer was the proud recipient of a Celebration Award in the Pharma Excipients Award category at CPhI China, held in Shanghai, June 24-26.
Notwithstanding the medium-term gains, the acquisition of JB Chemicals & Pharmaceuticals brings uncertainty over successful integration and generation of synergies.
Torrent Pharmaceuticals expects the Rs 19,500-crore deal to acquire majority stake in Mumbai-based J B Chemicals and Pharmaceuticals to complete over the next 15-18 months.
Torrent Pharmaceuticals Ltd. received a share price target upgrade from BofA Securities, on the likely synergies in operating margins that can help in earnings growth. BofA has raised the Torrent ...
Stocks to Watch today, Monday, June 30, 2025: Markets edged higher on Friday, extending the ongoing uptrend and ending the session with modest gains. In today’s trade, shares of Torrent Pharma, Tata ...
Torrent Pharmaceuticals added 2.22% to Rs 3,418.60 after the company entered into definitive agreement with KKR to acquire controlling stake in JB Chemicals and Pharmaceuticals at an equity valuation ...
Torrent will initially acquire 46.39% of JB Pharma for Rs 11,917 crore through a share purchase agreement at Rs 1,600 per share.
Torrent Pharmaceuticals aims to complete the acquisition of a majority stake in JB Chemicals for Rs 19,500 crore, bolstering its presence in the Indian pharmaceutical market. The merger offers ...
Torrent Pharma's Rs 11,917 crore stake buy from KKR and Rs 1,639/share open offer draws mixed analyst reactions; stock holds steady amid valuation and leverage discussions.
Torrent Pharma share pops 4% on ₹25,689-cr JB Chem deal; analysts cautious Torrent Pharmaceuticals has signed a definitive agreement to acquire a controlling stake in JB Chemicals and Pharmaceuticals ...
Shares of J B Chemicals and Pharmaceuticals tumbled nearly 7 per cent on Monday after Torrent Pharma announced the acquisition of a majority stake in the firm in a Rs 19,500-crore deal.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results